← Back to Search

Nutritional Supplements and Metabolite Intermediates

Mitochondrial Cocktail for Mitochondrial Disorder (MitoASD Trial)

Phase 1
Waitlist Available
Research Sponsored by Drexel University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (0), 3 and 6 months
Awards & highlights
All Individual Drugs Already Approved
Approved for 10 Other Conditions
No Placebo-Only Group

Summary

This trial involves giving children with autism and mitochondrial problems a special mix of vitamins and nutrients called the Mitochondrial Cocktail. The goal is to see if this treatment helps improve their condition by boosting cell energy production and protecting against damage. Researchers will check the children's progress through various tests at different stages of the treatment. The Mitochondrial Cocktail includes cofactors like L-Carnitine and the ketogenic diet, which have shown evidence for use in children with ASD.

Eligible Conditions
  • Mitochondrial Disorder
  • Autism Spectrum Disorder
  • Mitochondrial Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (0), 3 and 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (0), 3 and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Change in buccal oxidative stress markers and mitochondrial DNA (mtDNA) damage

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Mitochondrial CocktailExperimental Treatment1 Intervention
The precise content of the Mitochondrial Cocktail will be: * ubiquinol (liquid form, 150 mg/kg subject weight/day * carnitine, 50 mg/kg subject weight/day * alpha-lipoic acid, 100 mg/ day

Find a Location

Who is running the clinical trial?

Drexel UniversityLead Sponsor
154 Previous Clinical Trials
48,156 Total Patients Enrolled
Michael J Goldenthal, PhDStudy DirectorDrexel University College of Medicine
~5 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top